Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 9.1M | $103M | 0% | Mar 2024 |
|
| Paradigm Biocapital Advisors | 7.9M | $90M | 0% | Mar 2024 |
|
| Logos Global Management | 4.4M | $50M | 0% | Mar 2024 |
|
| BlackRock | 3.2M | $36M | 43% | Mar 2024 |
|
| Vanguard Group | 2.4M | $27M | -11% | Mar 2024 |
|
| MPM Oncology Impact Management | 2.0M | $22M | 5% | Mar 2024 |
|
| Dimensional Fund Advisors | 1.9M | $22M | 13% | Mar 2024 |
|
| Vivo Capital | 1.9M | $21M | 0% | Mar 2024 |
|
| Henderson Group | 1.2M | $14M | 74% | Mar 2024 |
|
| Geode Capital Management | 839k | $9.5M | 28% | Mar 2024 |
|
| Citadel Advisors | 806k | $9.1M | 136% | Mar 2024 |
|
| Woodline Partners | 750k | $8.5M | 5% | Mar 2024 |
|
| Braidwell | 704k | $8.0M | 100% | Mar 2024 |
|
| Soleus Capital Management | 658k | $7.4M | 100% | Mar 2024 |
|
| Victory Capital Management | 611k | $6.9M | -2% | Mar 2024 |
|
| Altium Capital Management | 605k | $6.8M | 81% | Mar 2024 |
|
| Marshall Wace | 548k | $6.2M | 88% | Mar 2024 |
|
| Morgan Stanley | 498k | $5.6M | 867% | Mar 2024 |
|
| Adage Capital Partners GP | 460k | $5.2M | 18% | Mar 2024 |
|
| Goldman Sachs Group | 437k | $4.9M | 39% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 353k | $4.0M | 64% | Mar 2024 |
|
| Northern Trust | 349k | $4.0M | 16% | Mar 2024 |
|
| Bank of America Corporation | 327k | $3.7M | 715% | Mar 2024 |
|
| Ameriprise Financial | 313k | $3.5M | -10% | Mar 2024 |
|
| Rafferty Asset Management | 295k | $3.3M | 100% | Mar 2024 |
|
| Citigroup | 250k | $2.8M | 5100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 249k | $2.8M | 0% | Mar 2024 |
|
| HighVista Strategies | 248k | $2.8M | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 204k | $2.3M | 100% | Mar 2024 |
|
| UBS Group | 173k | $2.0M | 230% | Mar 2024 |
|
| Newtyn Management | 150k | $1.7M | 0% | Mar 2024 |
|
| Two Sigma Advisers | 149k | $1.7M | -18% | Mar 2024 |
|
| Exome Asset Management | 143k | $1.6M | 100% | Mar 2024 |
|
| Monashee Investment Management | 135k | $1.5M | 100% | Mar 2024 |
|
| Ing Investment Management | 130k | $1.5M | 1095% | Mar 2024 |
|
| Verition Fund Management | 122k | $1.4M | 100% | Mar 2024 |
|
| Acadian Asset Management | 103k | $1.2M | -79% | Mar 2024 |
|
| Susquehanna International | 103k | $1.2M | -30% | Mar 2024 |
|
| Nuveen Asset Management | 101k | $1.1M | 0% | Mar 2024 |
|
| Wellington Management Company | 99k | $1.4M | 0% | Dec 2023 |
|
| Two Sigma Investments | 96k | $1.1M | -42% | Mar 2024 |
|
| Millennium Management | 88k | $999k | 1% | Mar 2024 |
|
| Charles Schwab Investment Management | 87k | $984k | -3% | Mar 2024 |
|
| Bank of New York Mellon | 81k | $920k | -20% | Mar 2024 |
|
| VR Adviser | 77k | $872k | 0% | Mar 2024 |
|
| Jacobs Levy Equity Management | 75k | $848k | -50% | Mar 2024 |
|
| Squarepoint Ops | 74k | $833k | 61% | Mar 2024 |
|
| Swiss National Bank | 70k | $796k | 9% | Mar 2024 |
|
| Hudson Bay Capital Management | 68k | $764k | 8% | Mar 2024 |
|
| ClariVest Asset Management | 61k | $694k | -7% | Mar 2024 |
|
| Cinctive Capital Management | 57k | $640k | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 52k | $588k | 100% | Mar 2024 |
|
| Credit Suisse | 47k | $537k | 9% | Mar 2024 |
|
| EP Wealth Advisors | 46k | $649k | 0% | Dec 2023 |
|
| ProFund Advisors | 45k | $512k | 100% | Mar 2024 |
|
| Barclays | 43k | $484k | -1% | Mar 2024 |
|
| Rhumbline Advisers | 41k | $468k | 3% | Mar 2024 |
|
| American Century Companies | 40k | $453k | 36% | Mar 2024 |
|
| ALPS Advisors | 38k | $535k | 100% | Dec 2023 |
|
| Jane Street | 36k | $404k | -1% | Mar 2024 |
|
| California State Teachers Retirement System | 35k | $393k | 486% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 35k | $392k | 100% | Mar 2024 |
|
| Springbok Capital Management | 33k | $370k | 100% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 29k | $326k | 35% | Mar 2024 |
|
| Legal & General Group | 27k | $309k | 11% | Mar 2024 |
|
| GSA Capital Partners | 27k | $306k | -39% | Mar 2024 |
|
| XTX Topco | 27k | $305k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 26k | $298k | 6% | Mar 2024 |
|
| State of Wisconsin Investment Board | 24k | $273k | -10% | Mar 2024 |
|
| Jpmorgan Chase & Co | 23k | $259k | -20% | Mar 2024 |
|
| Jump Financial | 20k | $278k | 100% | Dec 2023 |
|
| Alliancebernstein | 16k | $223k | 46% | Dec 2023 |
|
| Susquehanna Fundamental Investments | 16k | $176k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $209k | 0% | Dec 2023 |
|
| Walleye Trading Advisors | 15k | $164k | -49% | Mar 2024 |
|
| Entropy Technologies | 14k | $161k | 100% | Mar 2024 |
|
| Ensign Peak Advisors | 14k | $159k | 100% | Mar 2024 |
|
| E Fund Management | 14k | $158k | 100% | Mar 2024 |
|
| J. Goldman & Co | 14k | $153k | -73% | Mar 2024 |
|
| American International | 13k | $187k | 0% | Dec 2023 |
|
| Franklin Resources | 13k | $146k | 0% | Mar 2024 |
|
| AQR Capital Management | 11k | $126k | 6% | Mar 2024 |
|
| Sherbrooke Park Advisers | 11k | $127k | 100% | Mar 2024 |
|
| China Universal Asset Management | 11k | $120k | 67% | Mar 2024 |
|
| Mirae Asset Global Investments | 11k | $119k | -34% | Mar 2024 |
|
| D. E. Shaw & Co | 10k | $114k | -15% | Mar 2024 |
|
| Wells Fargo & Company | 9.7k | $110k | 14% | Mar 2024 |
|
| Zurcher Kantonalbank | 9.3k | $105k | 0% | Mar 2024 |
|
| Quest Partners | 8.2k | $93k | 100% | Mar 2024 |
|
| Virtus ETF Advisers | 7.0k | $80k | -6% | Mar 2024 |
|
| New York State Common Retirement Fund | 7.0k | $79k | 7% | Mar 2024 |
|
| Summit Investment Advisors | 2.2k | $25k | 0% | Mar 2024 |
|
| Simplex Trading | 2.2k | $24k | -88% | Mar 2024 |
|
| Tower Research Capital | 1.6k | $18k | 40% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.5k | $22k | 0% | Dec 2023 |
|
| Pacer Advisors | 1.4k | $16k | 100% | Mar 2024 |
|
| CWM | 1.0k | $12k | 0% | Mar 2024 |
|
| FMR | 996.00 | $11k | -39% | Mar 2024 |
|
| Amalgamated Bank | 906.00 | $10k | -61% | Mar 2024 |
|
| Royal Bank of Canada | 619.00 | $0 | -92% | Mar 2024 |
|
| Wolff Wiese Magana | 600.00 | $6.8k | 100% | Mar 2024 |
|
| Brian McDonald | 354.00 | $4.0k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 350.00 | $4.0k | 100% | Mar 2024 |
|
| Fortitude Family Office | 319.00 | $3.6k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 224.00 | $3.0k | 0% | Mar 2024 |
|
| Lindbrook Capital | 158.00 | $1.8k | 0% | Mar 2024 |
|
| Us Bancorp | 157.00 | $1.8k | 10% | Mar 2024 |
|
| Russell Investments | 37.00 | $418.999100 | 100% | Mar 2024 |
|
| GAMMA Investing | 14.00 | $157.999800 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 7.00 | $78.999900 | -82% | Mar 2024 |
|
| Covestor | 7.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 6.00 | $67.000200 | 100% | Mar 2024 |
|
Who sold out of Olema Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cormorant Asset Management | Dec 2023 | 2.5M | $35M |
| First Light Asset Management | Dec 2023 | 631k | $8.9M |
| Kingdon Capital Management | Dec 2023 | 550k | $7.7M |
| Perceptive Advisors | Dec 2023 | 540k | $7.6M |
| Eudaimonia Asset Management | Sep 2023 | 243k | $3.0M |
| Bridgeway Capital Management | Sep 2023 | 87k | $1.1M |
| Algert Coldiron Investors | Sep 2023 | 48k | $588k |
| Fred Alger Management | Dec 2023 | 40k | $555k |
| Caption Management | Dec 2023 | 27k | $379k |
| SG Americas Securities | Dec 2023 | 16k | $223k |
| Walleye Trading | Dec 2023 | 12k | $161k |
| Trexquant Investment | Sep 2023 | 11k | $138k |
| Dorsey Wright & Associates | Sep 2023 | 2.9k | $35k |
| Federated Investors | Sep 2023 | 1.0k | $13k |